It’s a well-known fact for anyone who has ever tried navigating the world of cancer clinical trials: Finding a research trial that’s a match for you isn’t easy. “It’s a kind of Wild West out there,” ...

Receiving a cancer diagnosis can cause fear, shock, and anxiety. You may be left with countless questions about what to do after finding out you have cancer. We are here to help you understand your ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly. Diagnosis involves the TNM system, Gleason score, PSA tests, and imaging to ...

Orserdu (elacestrant) is a targeted hormonal therapy for breast cancer. Unlike chemotherapy, which can harm both healthy and cancer cells, targeted therapy aims at specific proteins in the cancer ...

This guide for newly diagnosed patients provides key information to help you understand your options and have informed conversations with your oncologist. A diagnosis of head and neck cancer can bring ...

Cancer treatment is becoming more personalised. By considering a patient’s unique genetic and molecular profile, along with their lifestyle and environmental factors, doctors can make more accurate ...

Note: Molecular biologist and author Jeff Stewart has worked more than 15 years as a consultant to drugmakers, scrutinizing data on new treatments to fight cancer. Last July, the 50-year-old father of ...

Living with a cancer diagnosis can be mentally and physically overwhelming, and it’s natural to go through an array of emotions during this demanding time. Here’s what may help you cope. Living with ...

HER2-positive breast cancer is a type of breast cancer that grows and spreads quickly. If you have HER2-positive breast cancer, it means your cancer cells contain high levels of a protein called human ...

The central dogma of molecular biology describes the unidirectional flow of genetic information from DNA to RNA to protein, emphasizing the critical role of RNA as a messenger. Unlike DNA, RNA ...

Because of a lack of evidence-based guidelines and the challenges in diagnosing and managing CRCI, we propose a practical approach for oncologists to screen and discuss CRCI with patients routinely, ...